GILDNASDAQLive delayed
$130.52
+1.21+0.94%
SourceCNBCAs ofJul 27, 2026, 8:00 PM
Delayed market data from CNBC. Not investment advice.
Gilead is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for GILD · Finnhub.
- Market cap
- $164.01B
- P/E (TTM)
- 19.27
- EPS (TTM)
- $7.3515
- Div. yield
- 2.54%
- 52-week range
- $108.46 – $157.29
- Volume
- —
- Avg volume
- 5.87M
Price history
OHLC candles for GILD · 3mo · 1day · Twelve Data · EMA / RSI
-5.82%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
GILD Maintained by Morgan Stanley -- Price Target Lowered to $16GILD Maintained by Morgan Stanley -- Price Target Lowered to $16 GuruFocusBroad market headline — check whether risk appetite shifts.
Watch: GILD · .SPX · .FTSE · .N225
DirectHigh impactGoogle News
Gilead (GILD) Wins Key Europe Backing For Trodelvy In Triple Negative Breast CancerDirectHigh impactGoogle News
Gilead Sciences (GILD) Gets a Hold from RBC CapitalDirectHigh impactGoogle News
GILD Aug 2026 123.000 put (GILD260828P00123000) stock price, news, quote and historyDirectHigh impactGoogle News
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should KnowDirectHigh impactGoogle News
Gilead Sciences Inc (NASDAQ:GILD): A Quality Dividend Stock for Income InvestorsDirectHigh impactGoogle News
Gilead (GILD) Stock Could Still Trade At A Discount Following Its 127% RunDirectHigh impactGoogle News
Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026